Myrexis Announces Corporate Reorganization to Focus on Development Objectives
November 18, 2011 11:45 ET
|
Myrexis, Inc.
Internal Resources Realigned to Support Development Strategy
Further 20% Reduction in Workforce and $1.8 Million in Annual Cost Reduction
SALT LAKE CITY, Nov. 18, 2011 (GLOBE NEWSWIRE) --...
Myrexis Presents at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
November 14, 2011 09:05 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis Reports First Quarter Fiscal Year 2012 Results
November 09, 2011 16:11 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
CORRECTION -- Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
November 03, 2011 18:03 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Myrexis, Inc. (Nasdaq:MYRX) with the same headline, please note that the conference call will be held on...
Myrexis to Present at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
November 03, 2011 16:02 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
November 03, 2011 16:02 ET
|
Myrexis, Inc.
SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis Appoints Jason M. Aryeh to its Board of Directors
October 20, 2011 16:37 ET
|
Myrexis, Inc.
SALT LAKE CITY, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
Myrexis to Participate in the 2011 UBS Global Life Sciences Conference
September 14, 2011 16:00 ET
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
Myrexis to Present at 2011 Rodman and Renshaw Healthcare Conference
September 09, 2011 09:29 ET
|
Myrexis, Inc.
SALT LAKE CITY, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
Myrexis Reports Fourth Quarter and Fiscal Year 2011 Results
September 08, 2011 16:02 ET
|
Myrexis, Inc.
Clinical Development Strategy Update
Conference Call Today at 4:30 pm EDT
SALT LAKE CITY, Sept. 8, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the...